시장보고서
상품코드
1874002

심장 재활 시장

Cardiac Rehabilitation Market

발행일: | 리서치사: The Insight Partners | 페이지 정보: 영문 150 Pages | 배송안내 : 1-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 심장 재활 시장 규모는 2024년 24억 5,000만 달러로 평가되었고, 2031년까지 34억 달러로 성장할 것으로 예측되고 있으며, 2024-2031년 CAGR은 6.7%로 성장할 전망입니다. 이 시장을 견인하는 주요 동향에는 심장 재활 장비와 관련된 기술의 발전이 포함됩니다.

심장 재활 시장 분석

향후 10년간 각 기업에 의한 신제품의 도입이 심장 재활 서비스 수요 증가에 기여할 것으로 전망됩니다. 예를 들어, Omni VR의 'Virtual Rehabilitation System'은 착석시 및 입위시 모두에 대응하는 대화식으로 사용자 정의 가능한 활동을 제공합니다. 이 시스템은 기억력과 실행 기능을 활성화시키는 태스크를 도입함으로써 환자의 인지 기능 장애에 대한 대응을 도모하고 있습니다. 심장 재활에 대한 가상 접근법은 환자의 참여 의욕과 만족도를 높이고 기능적 결과를 향상시킵니다.

심장 재활 시장 개요

심장 재활 프로그램은 재입원률 감소에 효과적입니다. 그 예로는 지역사회 내에서 운영되는 종합적인 외래 심장 재활 서비스 '하트비트'를 들 수 있습니다. 세션은 자격을 갖춘 의료 전문가, 카운슬러, 일반 개업의에 의해 수행되며, 프로그램 운영자에게 피드백을 제공하며, 적절한 환자 선정, 출석 촉진, 복약 관리 지원, 심혈관 질환(CVD)의 위험 요인을 모니터링하고 치료합니다. 이러한 외래 프로그램은 향후 증가가 예상되는 심혈관 질환 관리에 매우 중요합니다.

전략적 인사이트

심장 재활 시장 성장 촉진요인 및 기회

시장 성장을 뒷받침하는 심혈관 질환 증가

미국 심장협회(AHA)의 보고에 따르면, 심혈관 질환(CVD)은 2020년에 92만 8,741명의 사망자를 낸 미국의 주요 사인이었습니다. 이 때문에 심근경색, 심부전 및 기타 외과적 또는 의학적 개입이 필요한 심장 질환에서 회복기에 있는 환자들에게 심장 재활의 중요성이 점점 커지고 있습니다. 이러한 심혈관 질환의 유병률 증가는 심장 재활 서비스 수요를 크게 견인해 세계 시장 점유율의 확대에 기여하고 있습니다.

가상 심장 재활 기회

재택 및 가상 심장 재활(CR) 프로그램은 전통적인 시설 CR에 대한 액세스 장벽을 효과적으로 제거하고 안전하고 유익한 서비스를 제공합니다. 이러한 가상 프로그램은 일반적으로 운동 옵션, 주간 뉴스레터, 심장 건강에 관한 실시간 토론, 가상 상담, 명상 세션을 포함한 전문 워크숍 등을 제공합니다. 예를 들어 카이저 퍼마넨테는 2024년 6월 가상 심장 재활 프로그램을 시작했으며, 2,300명 이상의 환자가 참여하여 미국 최대 규모의 프로그램 중 하나가 되었습니다. 이 노력으로 참가자의 심장 관련 재입원률은 같은 해 2% 미만으로 억제되었습니다. 따라서 가상 심장 재활은 2021년부터 2031년까지 시장 성장의 큰 기회를 제공할 것입니다.

심장 재활 시장의 부문 분석

심장 재활 시장 분석은 제품, 용도 및 최종 사용자를 기반으로 세분화됩니다.

  • 제품별로는 심박수 모니터, 밸런스볼, 트레드밀, 로잉 머신, 엘립티컬 트레이너, 혈압계, 에어로 자전거 등이 포함되어 2023년 시점에서 트레드밀 부문이 최대 시장 점유율을 차지했습니다.
  • 용도별로는 혈관성형술, 관상동맥질환, 심근증, 콜레스테롤 관리, 당뇨병, 폐이식으로 분류되며, 2023년에는 혈관성형술이 주요 부문이 되었습니다.
  • 최종 사용자별로는 병원 및 클리닉, 전문 병원, 재택 치료, 심장 재활센터 등으로 분류되었으며, 2023년에는 심장 재활센터가 시장 점유율을 지배했습니다.

심장 재활 시장의 지역 분석

심장 재활 시장의 지역별 시장 분석은 북미, 아시아태평양, 유럽, 중동, 아프리카, 중남미로 나뉩니다.

북미는 시장을 선도하고 있으며, 미국은 주요 심장 재활 서비스 제공업체의 존재 및 가상 재활 프로그램에 대한 정부의 지원으로 최대 점유율을 차지하고 있습니다. 아시아태평양은 향후 수년간 가장 높은 성장률을 기대하고 있습니다.

심장 재활 시장 보고서 범위

심장 재활 시장의 최근 발전

심장 재활 시장은 주요 기업 간행물, 협회 데이터, 데이터베이스를 포함한 1차 조사와 2차 조사에서 수집한 정성적 및 정량적 데이터를 통해 평가됩니다. 시장의 주요 발전은 다음과 같습니다.

  • Lupan Digital Health는 심장 전문의를 위한 세계 최초의 '디지털 치료학 인증'을 시작했습니다. 이 회사의 프로그램 'Lyfe'는 인도 최초의 임상적으로 검증된 원격 심장 재활 이니셔티브로 심장 건강 증진과 심혈관 질환 환자의 삶의 질 향상에 효과가 있음이 입증되었습니다.(출처 : 루팡, 기업 웹사이트, 2024년 1월)

심장 재활 시장 보고서의 내용과 아티팩트

'심장 재활 시장 규모 및 예측(2021-2031년)'이라는 제목의 보고서는 다음 영역을 포괄하는 종합적인 시장 분석을 제공합니다.

  • 주요 부문별 세계, 지역, 국가 수준에서 시장 규모 및 예측
  • 시장 동향 및 시장 역학(촉진요인, 억제요인, 주요 기회 포함)
  • 상세한 PEST 및 Porter's Five Forces 분석, SWOT 분석
  • 주요 동향, 주요 기업, 규제, 최근 동향을 망라한 세계 및 지역별 시장 분석
  • 업계 정세 및 경쟁 분석(시장 집중도, 히트맵 분석, 주요기업, 최근 발전 포함)
  • 상세한 기업 프로파일

목차

제1장 서론

제2장 심장 재활 시장 및 주요 포인트

제3장 조사 방법

  • 조사 범위
  • 2차 조사
  • 1차 조사

제4장 세계의 심장 재활 시장 및 시장 상황

  • PEST 분석
    • 북미 : PEST 분석
    • 유럽 : PEST 분석
    • 아시아태평양 : PEST 분석
    • 중동 및 아프리카(MEA) : PEST 분석
    • 중남미(SCAM) : PEST 분석
  • 전문가의 견해

제5장 심장 재활 시장 및 주요 시장 역학

  • 시장 성장 촉진요인
    • 심혈관 질환 발생률의 상승
    • 원격 심장 재활의 도입 확대
  • 시장 성장 억제요인
    • 심장 재활 장비의 고비용
  • 시장 기회
    • 정부에 의한 지원 시책
  • 향후의 동향
    • 기술적으로 고급 심장 재활 제품 증가
  • 영향 분석

제6장 심장 재활 시장 : 세계 분석

  • 세계의 심장 재활 시장 수익 예측 및 분석
  • 세계의 심장 재활 시장 예측 및 분석 : 지역별
  • 주요 기업의 시장 포지셔닝

제7장 심장 재활 시장 분석 : 제품별

  • 심장 재활 시장의 수익 점유율 : 제품별(2020년, 2031년)
  • 심박수 모니터
  • 밸런스볼
  • 트레드밀
  • 로잉 머신
  • 엘립티컬 트레이너
  • 혈압계
  • 에어로 오토바이
  • 기타

제8장 심장 재활 시장 분석 : 용도별

  • 심장 재활 시장의 수익 점유율 : 용도별(2020년, 2031년)
  • 혈관성형술
  • 관상동맥질환
  • 심근증
  • 콜레스테롤 관리
  • 당뇨병
  • 폐 이식

제9장 심장 재활 시장 분석 : 최종 사용자별

  • 심장 재활 시장 : 최종 사용자별(2020년 및 2031년,%)
  • 병원 및 클리닉
    • 병원 및 클리닉 : 심장 재활 시장 수익 및 예측(-2031년)
  • 재택 치료
    • 재택치료 : 심장 재활 시장 수익 및 예측(-2031년)
  • 전문 병원
    • 전문 병원 : 심장 재활 시장 수익 및 예측(-2031년)
  • 심장 재활센터
    • 심장 재활센터 : 심장 재활 시장 수익 및 예측(-2031년)
  • 기타
    • 기타 : 심장 재활 시장 수익 및 예측(-2031년)

제10장 세계의 심장 재활 시장 : 지역별 분석

  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 기타 유럽
  • 아시아태평양
    • 일본
    • 중국
    • 인도
    • 한국
    • 호주
    • 기타 아시아태평양
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 남아프리카
    • 기타 중동 및 아프리카
  • 중남미
    • 브라질
    • 아르헨티나
    • 기타 중남미

제11장 COVID-19 팬데믹이 세계 심장 재활 시장에 미치는 영향

  • 북미
  • 유럽
  • 아시아태평양
  • 중동 및 아프리카
  • 중남미

제12장 심장 재활 시장 및 업계의 개황

  • 시장에서 기업의 성장 전략(%)
  • 유기적 발전
  • 무기적 발전

제13장 기업 프로파일

  • Halma plc
  • OMRON Corporation
  • AVECINNA
  • Koninklijke Philips NV
  • General Electric Company
  • Core Health and Fitness, LLC
  • Peloton Interactive, Inc.
  • Resideo Technologies, Inc
  • ergoline GmbH
  • HealthCare International
AJY 25.12.12

The cardiac rehabilitation market is anticipated to grow from US$ 2.45 billion in 2024 to US$ 3.4 billion by 2031, reflecting a compound annual growth rate (CAGR) of 6.7% during the period from 2031 to 2031. Key trends driving this market include advancements in technology related to cardiac rehabilitation devices.

Analysis of the Cardiac Rehabilitation Market

New product introductions by companies are expected to boost the demand for cardiac rehabilitation services over the next decade. For instance, OmniVR's "Virtual Rehabilitation System" features interactive, customizable activities for both seated and standing positions. This system addresses cognitive impairments in patients by incorporating tasks that engage memory and executive functions. The virtual approach to cardiac rehabilitation enhances patient engagement and enjoyment, leading to improved functional outcomes.

Overview of the Cardiac Rehabilitation Market

Cardiac rehabilitation programs are effective in lowering hospital readmission rates. An example is "HeartBeat," a comprehensive outpatient cardiac rehabilitation service that operates within the community. Sessions are conducted by qualified health professionals, counselors, and general practitioners who provide feedback to program organizers, select appropriate patients, encourage attendance, assist with medication management, and monitor and treat cardiovascular disease (CVD) risk factors. Such outpatient programs are crucial in managing the increasing rates of cardiovascular diseases in the coming years.

Strategic Insights

Drivers and Opportunities in the Cardiac Rehabilitation Market

Increasing Cardiovascular Diseases Favoring Market Growth

As reported by the American Heart Association, cardiovascular disease (CVD) was the leading cause of death in the US, resulting in 928,741 fatalities in 2020. Consequently, the rise in cardiovascular diseases underscores the importance of cardiac rehabilitation for individuals recovering from heart attacks, heart failure, and other cardiac issues requiring surgical or medical intervention. This growing prevalence of cardiovascular diseases is a significant driver of demand for cardiac rehabilitation services, thereby enhancing the global market share.

Opportunities in Virtual Cardiac Rehabilitation

Home-based or virtual cardiac rehabilitation (CR) programs can effectively eliminate barriers to accessing traditional center-based CR, providing safe and beneficial services. These virtual programs typically offer exercise options, weekly newsletters, live discussions on heart health, virtual consultations, and specialized workshops, including meditation sessions. For example, Kaiser Permanente launched a virtual cardiac rehabilitation program in June 2024, enrolling over 2,300 patients, making it one of the largest programs in the US. This initiative resulted in cardiac-related hospital readmissions for participants being less than 2% in the same year. Thus, virtual cardiac rehabilitation presents a significant opportunity for market growth from 2021 to 2031.

Segmentation Analysis of the Cardiac Rehabilitation Market

The cardiac rehabilitation market analysis is segmented based on type, cause, disorder type, category, and end user.

  • By product, the market includes heart rate monitors, stabilization balls, treadmills, elliptical trainers, blood pressure monitors, stationary bicycles, and others, with the treadmill segment holding the largest market share in 2023.
  • By application, the market is divided into angioplasty, coronary artery disease, cardiomyopathy, cholesterol management, diabetes, and lung transplant, with angioplasty being the leading segment in 2023.
  • By end user, the market is categorized into hospitals & clinics, specialty hospitals, home healthcare, cardiac rehabilitation centers, and others, with cardiac rehabilitation centers dominating the market share in 2023.

Geographical Analysis of the Cardiac Rehabilitation Market

The geographic analysis of the Cardiac Rehabilitation market is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America leads the market, with the US holding the largest share due to the presence of top cardiac rehabilitation service providers and government support for virtual rehabilitation programs. The Asia Pacific region is expected to experience the highest growth rate in the coming years.

Scope of the Cardiac Rehabilitation Market Report

Recent Developments in the Cardiac Rehabilitation Market

The Cardiac Rehabilitation market is assessed through qualitative and quantitative data collected from primary and secondary research, including significant corporate publications, association data, and databases. Notable developments in the market include:

  • Lupin Digital Health has launched the world's first "Digital Therapeutics Certificate" for cardiologists. Their program "Lyfe" is India's first clinically validated remote cardiac rehabilitation initiative, proven to enhance heart health and improve the quality of life for cardiovascular patients. (Source: Lupin, Company Website, January 2024)

Coverage and Deliverables of the Cardiac Rehabilitation Market Report

The report titled "Cardiac Rehabilitation Market Size and Forecast (2021-2031)" provides a comprehensive analysis of the market, covering the following areas:

  • Market size and forecast at global, regional, and country levels for all key segments.
  • Market trends and dynamics, including drivers, restraints, and key opportunities.
  • Detailed PEST/Porter's Five Forces and SWOT analysis.
  • Market analysis covering key trends, global and regional frameworks, major players, regulations, and recent developments.
  • Industry landscape and competition analysis, including market concentration, heat map analysis, prominent players, and recent developments.
  • In-depth company profiles.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Cardiac Rehabilitation Market and By Product
    • 1.3.2 Global Cardiac Rehabilitation Market and By Application
    • 1.3.3 Global Cardiac Rehabilitation Market and By End User
    • 1.3.4 Global Cardiac Rehabilitation Market and By Geography

2. Cardiac Rehabilitation Market and Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Cardiac Rehabilitation Market and Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America and PEST Analysis
    • 4.2.2 Europe and PEST Analysis
    • 4.2.3 Asia Pacific and PEST Analysis
    • 4.2.4 Middle East and Africa (MEA) and PEST Analysis
    • 4.2.5 South and Central America (SCAM) and PEST Analysis
  • 4.3 Expert Opinions

5. Cardiac Rehabilitation Market and Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Incidences of Cardiovascular Diseases
    • 5.1.2 Growing Adoption of Tele-Cardiac Rehabilitation
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Cardiac Rehabilitation Equipment
  • 5.3 Market Opportunities
    • 5.3.1 Supportive Government Initiatives
  • 5.4 Future Trends
    • 5.4.1 Rise in Technologically Advanced Cardiac Rehabilitation Products
  • 5.5 Impact Analysis

6. Cardiac Rehabilitation Market and Global Analysis

  • 6.1 Global Cardiac Rehabilitation Market Revenue Forecast and Analysis
  • 6.2 Global Cardiac Rehabilitation Market, By Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players

7. Cardiac Rehabilitation Market Analysis and By Products

  • 7.1 Overview
  • 7.2 Cardiac Rehabilitation Market Revenue Share, by Products (2020 and 2031)
  • 7.3 Heart Rate Monitors
    • 7.3.1 Overview
    • 7.3.2 Heart Rate Monitors: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 7.4 Stabilization Balls
    • 7.4.1 Overview
    • 7.4.2 Stabilization Balls: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 7.5 Treadmill
    • 7.5.1 Overview
    • 7.5.2 Treadmill: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 7.6 Rower
    • 7.6.1 Overview
    • 7.6.2 Rower: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 7.7 Elliptical Trainer
    • 7.7.1 Overview
    • 7.7.2 Elliptical Trainer: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 7.8 Blood Pressure Monitor
    • 7.8.1 Overview
    • 7.8.2 Blood Pressure Monitor: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 7.9 Stationary Bicycle
    • 7.9.1 Overview
    • 7.9.2 Stationary Bicycle: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 7.10 Others
    • 7.10.1 Overview
    • 7.10.2 Others: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)

8. Cardiac Rehabilitation Market Analysis and By Application

  • 8.1 Overview
  • 8.2 Cardiac Rehabilitation Market Revenue Share, by Application (2020 and 2031)
  • 8.3 Angioplasty
    • 8.3.1 Overview
    • 8.3.2 Angioplasty: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 8.4 Coronary Artery Disease
    • 8.4.1 Overview
    • 8.4.2 Coronary Artery Disease: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 8.5 Cardiomyopathy
    • 8.5.1 Overview
    • 8.5.2 Cardiomyopathy: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 8.6 Cholesterol Management
    • 8.6.1 Overview
    • 8.6.2 Cholesterol Management: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 8.7 Diabetes
    • 8.7.1 Overview
    • 8.7.2 Diabetes: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 8.8 Lung Transplant
    • 8.8.1 Overview
    • 8.8.2 Lung Transplant: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)

9. Cardiac Rehabilitation Marketand By End User

  • 9.1 Overview
  • 9.2 Cardiac Rehabilitation Market, by Distribution Channel, 2020 and 2031 (%)
  • 9.3 Hospitals and Clinics
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Clinics: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 9.4 Home Healthcare
    • 9.4.1 Overview
    • 9.4.2 Home Healthcare: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 9.5 Specialty Hospitals
    • 9.5.1 Overview
    • 9.5.2 Specialty Hospitals: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 9.6 Cardiac Rehabilitation Centers
    • 9.6.1 Overview
    • 9.6.2 Cardiac Rehabilitation Centers: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 9.7 Others
    • 9.7.1 Overview
    • 9.7.2 Others: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)

10. Global Cardiac Rehabilitation Market and Geographical Analysis

  • 10.1 North America: Cardiac Rehabilitation Market
    • 10.1.1 Overview
    • 10.1.2 North America: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
    • 10.1.3 North America: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
    • 10.1.4 North America: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
    • 10.1.5 North America: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
    • 10.1.6 North America: Cardiac Rehabilitation Market, by Country, 2020 and 2031 (%)
      • 10.1.6.1 US: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.1.6.1.1 US: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.1.6.1.2 US: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.1.6.1.3 US: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.1.6.1.4 US: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.1.6.2 Canada: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.1.6.2.1 Canada: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.1.6.2.2 Canada: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.1.6.2.3 Canada: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.1.6.2.4 Canada: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.1.6.3 Mexico: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.1.6.3.1 Mexico: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.1.6.3.2 Mexico: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.1.6.3.3 Mexico: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.1.6.3.4 Mexico: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
  • 10.2 Europe: Cardiac Rehabilitation Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Cardiac Rehabilitation Market - Revenue and Forecasts to 2031 (USD Million)
    • 10.2.3 Europe: Cardiac Rehabilitation Market, by Device, 2024 and 2031 (USD Million)
    • 10.2.4 Europe: Cardiac Rehabilitation Market, by Application 2024 and 2031 (USD Million)
    • 10.2.5 Europe: Cardiac Rehabilitation Market, by End-User 2024 and 2031 (USD Million)
    • 10.2.6 Europe: Cardiac Rehabilitation Market, by Country, 2020 and 2031 (%)
      • 10.2.6.1 Germany: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.1.1 Germany: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.1.2 Germany: Cardiac rehabilitation Market, by Product 2024 and 2031 (USD Million)
        • 10.2.6.1.3 Germany: Cardiac rehabilitation Market, by Application 2024 and 2031 (USD Million)
        • 10.2.6.1.4 Germany: Cardiac rehabilitation Market, by End-User 2024 and 2031 (USD Million)
      • 10.2.6.2 UK: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.2.1 UK: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.2.2 UK: Cardiac Rehabilitation Market, Product, 2024 and 2031 (USD Million)
        • 10.2.6.2.3 UK: Cardiac Rehabilitation Market, by Application 2024 and 2031 (USD Million)
        • 10.2.6.2.4 UK: Cardiac Rehabilitation Market, by End-User 2024 and 2031 (USD Million)
      • 10.2.6.3 France: Cardiac rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.3.1 France: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.3.2 France: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.2.6.3.3 France: Cardiac Rehabilitation Market, by Application 2024 and 2031 (USD Million)
        • 10.2.6.3.4 France: Cardiac Rehabilitation Market, by End-User 2024 and 2031 (USD Million)
      • 10.2.6.4 Italy: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.4.1 Italy: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.4.2 Italy: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.2.6.4.3 Italy: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.2.6.4.4 Italy: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.2.6.5 Spain: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.5.1 Spain: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.5.2 Spain: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.2.6.5.3 Spain: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.2.6.5.4 Spain: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.2.6.6 Rest of Europe: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.6.1 Rest of Europe: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.6.2 Rest of Europe: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.2.6.6.3 Rest of Europe: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.2.6.6.4 Rest of Europe: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
  • 10.3 Asia Pacific: Cardiac Rehabilitation Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Cardiac Rehabilitation Market - Revenue and Forecasts to 2031 (USD Million)
    • 10.3.3 Asia Pacific: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
    • 10.3.4 Asia Pacific: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
    • 10.3.5 Asia Pacific: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
    • 10.3.6 Asia Pacific: Cardiac Rehabilitation Market, by Country, 2020 and 2031 (%)
      • 10.3.6.1 Japan: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.1.1 Japan: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.1.2 Japan: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.3.6.1.3 Japan: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.3.6.1.4 Japan: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.3.6.2 China: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.2.1 China: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.2.2 China: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.3.6.2.3 China: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.3.6.2.4 China: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.3.6.3 India: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.3.1 India: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.3.2 India: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.3.6.3.3 India: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.3.6.3.4 India: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.3.6.4 South Korea: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.4.1 South Korea: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.4.2 South Korea: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.3.6.4.3 South Korea: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.3.6.4.4 South Korea: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.3.6.5 Australia: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.5.1 Australia: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.5.2 Australia: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.3.6.5.3 Australia: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.3.6.5.4 Australia: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.3.6.6 Rest of Asia Pacific: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.6.1 Rest of Asia Pacific: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.6.2 Rest of Asia Pacific: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.3.6.6.3 Rest of Asia Pacific: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.3.6.6.4 Rest of Asia Pacific: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
  • 10.4 Middle East and Africa: Cardiac Rehabilitation Market
    • 10.4.1 Overview
    • 10.4.2 Middle East and Africa: Cardiac Rehabilitation Market - Revenue and Forecasts to 2031 (USD Million)
    • 10.4.3 Middle East and Africa: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
    • 10.4.4 Middle East and Africa: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
    • 10.4.5 Middle East and Africa: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
    • 10.4.6 Middle East and Africa: Cardiac Rehabilitation Market, by Country, 2020 and 2031 (%)
      • 10.4.6.1 Saudi Arabia: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.4.6.1.1 Saudi Arabia: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.4.6.1.2 Saudi Arabia: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.4.6.1.3 Saudi Arabia: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.4.6.1.4 Saudi Arabia: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.4.6.2 UAE: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.4.6.2.1 UAE: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.4.6.2.2 UAE: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.4.6.2.3 UAE: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.4.6.2.4 UAE: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.4.6.3 South Africa: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.4.6.3.1 South Africa: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.4.6.3.2 South Africa: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.4.6.3.3 South Africa: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.4.6.3.4 South Africa: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.4.6.4 Rest of Middle East and Africa: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.4.6.4.1 Rest of Middle East and Africa: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.4.6.4.2 Rest of Middle East and Africa: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.4.6.4.3 Rest of Middle East and Africa: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.4.6.4.4 Rest of Middle East and Africa: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
  • 10.5 South and Central America: Cardiac Rehabilitation Market
    • 10.5.1 Overview
    • 10.5.2 South and Central America: Cardiac Rehabilitation Market - Revenue and Forecasts to 2031 (USD Million)
    • 10.5.3 South and Central America: Cardiac Rehabilitation Market, by Product, 2019 -2031 (USD Million)
    • 10.5.4 South and Central America: Cardiac Rehabilitation Market, by Application, 2019 -2031 (USD Million)
    • 10.5.5 South and Central America: Cardiac Rehabilitation Market, by End User, 2019 -2031 (USD Million)
    • 10.5.6 South and Central America: Cardiac Rehabilitation Market Share by Country and 2020 and 2031, (%)
      • 10.5.6.1 Brazil: Cardiac Rehabilitation Market- Revenue and Forecasts to 2031 (USD Million)
        • 10.5.6.1.1 Brazil: Cardiac Rehabilitation Market- Revenue and Forecasts to 2031 (USD Million)
        • 10.5.6.1.2 Brazil: Cardiac Rehabilitation Market, by Product, 2019 -2031 (USD Million)
        • 10.5.6.1.3 Brazil: Cardiac Rehabilitation Market, by Application, 2019-2031 (USD Million)
        • 10.5.6.1.4 Brazil: Cardiac Rehabilitation Market, by End User, 2019-2031 (USD Million)
      • 10.5.6.2 Argentina: Cardiac Rehabilitation Market- Revenue and Forecasts to 2031 (USD Million)
        • 10.5.6.2.1 Argentina: Cardiac Rehabilitation Market- Revenue and Forecasts to 2031 (USD Million)
        • 10.5.6.2.2 Argentina: Cardiac Rehabilitation Market, by Product, 2019 -2031 (USD Million)
        • 10.5.6.2.3 Argentina: Cardiac Rehabilitation Market, by Application, 2019 -2031 (USD Million)
        • 10.5.6.2.4 Argentina: Cardiac Rehabilitation Market, by End User, 2019 -2031 (USD Million)
      • 10.5.6.3 Rest of South and Central America: Cardiac Rehabilitation Market- Revenue and Forecasts to 2031 (USD Million)
        • 10.5.6.3.1 Rest of South and Central America: Cardiac Rehabilitation Market- Revenue and Forecasts to 2031 (USD Million)
        • 10.5.6.3.2 Rest of South and Central America: Cardiac Rehabilitation Market, by Product, 2019 -2031 (USD Million)
        • 10.5.6.3.3 Rest of South and Central America: Cardiac Rehabilitation Market, by Application, 2019-2031 (USD Million)
        • 10.5.6.3.4 Rest of South and Central America: Cardiac Rehabilitation Market, by End User, 2018-2027 (USD Million)

11. Impact Of COVID-19 Pandemic on Global Cardiac Rehabilitation Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
  • 11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Cardiac Rehabilitation MarketandIndustry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies Done by the Companies in the Market, (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Halma plc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 OMRON Corporation
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 AVECINNA
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Koninklijke Philips N.V.
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 General Electric Company
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Core Health and Fitness, LLC
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Peloton Interactive, Inc.
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Resideo Technologies, Inc
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 ergoline GmbH
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 HealthCare International
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제